Trade

with

Techne Corp
(NASDAQ: TECH)
AdChoices
93.24
+0.13
+0.14%
After Hours :
93.25
+0.01
+0.01%

Open

93.57

Previous Close

93.11

Volume (Avg)

181.31k (184.05k)

Day's Range

92.82-94.21

52Wk Range

82.51-97.15

Market Cap.

3.45B

Dividend Rate (Yield )

1.24 (1.33%)

Beta

0.64

Shares Outstanding

37.01M

P/E Ratio (EPS)

31.06 (3.00)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 357.76M

    • Net Income

    • 110.95M

    • Market Cap.

    • 3.45B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 31.01

    • PEG (Price/Earnings Growth) Ratio

    • 1.61

    • Beta

    • 0.64

    • Forward P/E

    • 24.75

    • Price/Sales

    • 9.64

    • Price/Book Value

    • 4.34

    • Price/Cash flow

    • 24.51

      • EBITDA

      • 178.92M

      • Return on Capital %

      • 13.53

      • Return on Equity %

      • 14.48

      • Return on Assets %

      • 13.53

      • Book Value/Share

      • 21.49

      • Shares Outstanding

      • 37.01M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.31 (8/19/2014)

      • Dividend Declaration Date

      • 8/11/2014

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 112.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • 3.22

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 16.40

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -1.40

          • 17.04

          • Net Income

            Q/Q (last year)

          • -5.60

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 6.27

          • 63.43

          • Net Income

            5-Year Annual Average

          • 1.10

          • 10.65

          • Dividends

            5-Year Annual Average

          • 10.40

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 70.27

            • 82.75

            • Pre-Tax Margin

            • 45.11

            • 39.38

            • Net Profit Margin

            • 31.01

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 75.40

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 52.70

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • 36.50

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.01

              • 0.76

              • Current Ratio

              • 17.79

              • 2.92

              • Quick Ratio

              • 15.85

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.08

              • 2.21

              • Book Value/Share

              • 21.49

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 30.21

                • 243.90

                • P/E Ratio 5-Year High

                • 32.40

                • 634.30

                • P/E Ratio 5-Year Low

                • 18.55

                • 124.82

                • Price/Sales Ratio

                • 9.36

                • 9.29

                • Price/Book Value

                • 4.21

                • 8.39

                • Price/Cash Flow Ratio

                • 24.51

                • 49.75

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 41.02

                    • Dividend Date

                    • 8/11/2014

                    • Ex-Dividend Date

                    • 8/19/2014

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 14.48

                        (18.40)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • 13.53

                        (17.50)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • 14.24

                        (18.30)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • 108.67k

                      • 117.08k

                      • Inventory Turnover

                      • 2.89

                      • 1.48

                      • Asset Turnover

                      • 0.44

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      159.75M
                      Operating Margin
                      44.65
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      24.51
                      Ownership

                      Institutional Ownership

                      99.84%

                      Top 10 Institutions

                      40.16%

                      Mutual Fund Ownership

                      55.88%

                      Float

                      98.34%

                      5% / Insider Ownership

                      3.54%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Brown Capital Management Small Company

                      •  

                        1,131,164

                      • 0.00

                      • 3.06

                      • Columbia Acorn Fund

                      •  

                        936,000

                      • 0.00

                      • 2.53

                      • Baron Growth Fund

                      •  

                        880,943

                      • 0.00

                      • 2.38

                      • Delaware SMID Cap Growth Collective Investment Trust

                      •  

                        722,000

                      • -1.18

                      • 1.95

                      • Delaware Smid Cap Growth Fund

                      •  

                        722,000

                      • -1.18

                      • 1.95

                      • Mairs & Power Growth Fund

                      •  

                        720,000

                      • 0.00

                      • 1.95

                      • Vanguard Small Cap Index

                      •  

                        642,584

                      • -0.34

                      • 1.74

                      • Buffalo Small Cap Fund

                      •  

                        636,000

                      • 0.00

                      • 1.72

                      • Neuberger Berman Genesis Fund

                      •  

                        609,300

                      • -2.15

                      • 1.65

                      • Vanguard Total Stock Mkt Idx

                      •  

                        606,030

                      • 0.72

                      • 1.64

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Group, Inc.

                      •  

                        2,250,332

                      • -0.05%

                      • 6.08

                      • Brown Capital Management, LLC

                      •  

                        2,079,877

                      • -4.11%

                      • 5.62

                      • Blair William & Co

                      •  

                        1,452,556

                      • -9.20%

                      • 3.93

                      • BlackRock Fund Advisors

                      •  

                        1,399,160

                      • +2.66%

                      • 3.78

                      • Janus Capital Management LLC

                      •  

                        1,378,525

                      • -4.95%

                      • 3.73

                      • Delaware Management Business Trust

                      •  

                        1,295,741

                      • -31.86%

                      • 3.50

                      • Columbia Wanger Asset Management LLC

                      •  

                        1,212,200

                      • +58.73%

                      • 3.28

                      • Mairs & Power Inc

                      •  

                        1,095,391

                      • +10.00%

                      • 2.96

                      • BAMCO Inc

                      •  

                        1,053,380

                      • 0.00%

                      • 2.85

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Slow Growth

                      Style

                      Small Growth

                      Techne Corp is engaged in the development, manufacture and sale of biotechnology products and clinical diagnostic controls. Its business is segmented into two areas - Biotechnology and Hematology. The Biotechnology segment offers pr...moreoteins, such as cytokines, and enzyme substrates and inhibitors; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits for the detection of human and animal proteins, and immunoassays that allow researchers to quantify a specific analyte in a biological fluids sample; clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and beta2-microglobulin immunoassays for use as in vitro diagnostic devices; flow cytometry products, such as fluorochrome labeled antibodies and kits; intracellular cell si...moregnaling products, including antibodies, phospho-specific antibodies, antibody arrays, active caspases, kinases, phosphatases, and enzyme-linked immunosorbant assays to measure the activity of apoptotic and signaling molecules; and natural and synthetic chemical compounds for use as agonists, antagonists, and inhibitors of various biological functions by investigators. The Hematology segment provides a range of hematology controls and calibrators for impedance and laser type cell counters; and hematology control products for use as proficiency testing tools by laboratory certifying authorities. The Company serves biotechnology research market and the clinical diagnostics market.lessless

                      Key People

                      Mr. Charles R. Kummeth

                      CEO/Director/President

                      Dr. Roger C. Lucas, PhD

                      Director/Vice Chairman of the Board

                      Mr. Robert V. Baumgartner, C.P.A.

                      Chairman of the Board/Director

                      James Hippel

                      CFO/Chief Accounting Officer/Vice President, Divisional

                      Dr. Charles A. Dinarello,M.D.

                      Director

                      • Techne Corp

                      • 614 McKinley Place North East

                      • Minneapolis, MN 55413-2610

                      • USA.Map

                      • Phone: +1 612 379-8854

                      • Fax: +1 612 656-4400

                      • bio-techne.com

                      Incorporated

                      1976

                      Employees

                      1,021

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: